Catalyst Wire Dossier Catalyst Wire Dossier

Beltaven

· Probelte Pharma S.L.U.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Beltaven, covering 2025-12-30 to 2025-12-30. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety and Effectiveness of Beltaven® in Patients With Allergy to Apis Mellifera, Polistes Dominula or Vespula Spp.

See pricing